Keywords: zentaris, gets, eu, orphan, drug, status, miltefosine

Zentaris gets EU orphan drug status for miltefosine

Article | 20 May 2002

Print This

Zentaris, an affiliate of Degussa AG of Germany, has been grantedorphan drug status by the European Union for its miltefosine, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in